Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma

Respiratory Medicine

Volumn 109, Issue 11, 2015, Pages 1391-1396

  Liu, Tian ^a   Wu, Jinxiang ^a   Zhao, Jiping ^a   Wang, Junfei ^a   Zhang, Yuanyuan ^a   Liu, Lin ^a   Cao, Liuzhao ^a   Liu, Yahui ^a   Dong, Liang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Asthma; Biomarker; Eosinophilic inflammation; ILC2

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN E; NITRIC OXIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASTHMA; BODY MASS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EOSINOPHIL COUNT; EOSINOPHILIC AIRWAY INFLAMMATION; FEMALE; FORCED EXPIRATORY VOLUME; FRACTIONAL EXHALED NITRIC OXIDE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; LUNG FUNCTION TEST; LYMPHOID CELL; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT PARAMETERS; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; TYPE 2 INNATE LYMPHOID CELL; BLOOD; BREATH ANALYSIS; CASE CONTROL STUDY; COMPLICATION; CYTOLOGY; EOSINOPHIL; EVALUATION STUDY; FEASIBILITY STUDY; IMMUNOLOGY; INNATE IMMUNITY; LEUKOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; PULMONARY EOSINOPHILIA; SPUTUM;

ADULT; ASTHMA; BIOMARKERS; BREATH TESTS; CASE-CONTROL STUDIES; EOSINOPHILS; FEASIBILITY STUDIES; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN E; LEUKOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; NITRIC OXIDE; PULMONARY EOSINOPHILIA; SPUTUM;

EID: 84947029376     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2015.09.016     Document Type: Article

References (33)

1. G.P. Anderson Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease Lancet 372 2008 1107 1119
2. S.E. Wenzel Asthma: defining of the persistent adult phenotypes Lancet 368 2006 804 813
3. H.L. Petsky, C.J. Cates, T.J. Lasserson, A.M. Li, C. Turner, J.A. Kynaston, and et al. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils) Thorax 67 2012 199 208
4. D.A. Korevaar, G.A. Westerhof, J. Wang, J.F. Cohen, R. Spijker, P.J. Sterk, and et al. Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis Lancet Respir. Med. 3 2015 290 300
5. A.H. Wagener, S.B. de Nijs, R. Lutter, A.R. Sousa, E.J. Weersink, E.H. Bel, and et al. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma Thorax 70 2015 115 120
6. S.T. Scanlon, and A.N. McKenzie The messenger between worlds: the regulation of innate and adaptive type-2 immunity by innate lymphoid cells Clin. Exp. Allergy 45 2015 9 20
7. H.H. Walford, S.J. Lund, R.E. Baum, A.A. White, C.M. Bergeron, J. Husseman, and et al. Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness Clin. Immunol. 155 2014 126 135
8. B.S. Kim, M.C. Siracusa, S.A. Saenz, M. Noti, L.A. Monticelli, G.F. Sonnenberg, and et al. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation Sci. Transl. Med. 5 2013 170ra16
9. K.R. Bartemes, G.M. Kephart, S.J. Fox, and H. Kita Enhanced innate type 2 immune response in peripheral blood from patients with asthma J. Allergy Clin. Immunol. 134 2014 671.e4-678.e4
10. M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, and et al. Standardisation of spirometry Eur. Respir. J. 26 2005 319 338
11. R.A. Dweik, P.B. Boggs, S.C. Erzurum, C.G. Irvin, M.W. Leigh, J.O. Lundberg, and et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications Am. J. Respir. Crit. Care Med. 184 2011 602 615
12. S. American Thoracic, and S. European Respiratory ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide Am. J. Respir. Crit. Care Med. 171 2005 912 930
13. P.L. Paggiaro, P. Chanez, O. Holz, P.W. Ind, R. Djukanovic, P. Maestrelli, and et al. Sputum induction Eur. Respir. J. Suppl. 37 2002 3s 8s
14. I.D. Pavord, C.E. Brightling, G. Woltmann, and A.J. Wardlaw Non-eosinophilic corticosteroid unresponsive asthma Lancet 353 1999 2213 2214
15. L.B. Martin, H. Kita, K.M. Leiferman, and G.J. Gleich Eosinophils in allergy: role in disease, degranulation, and cytokines Int. Arch. Allergy Immunol. 109 1996 207 215
16. H.F. Rosenberg, S. Phipps, and P.S. Foster Eosinophil trafficking in allergy and asthma J. Allergy Clin. Immunol. 119 2007 11 12 1303-10; quiz
17. D.S. Robinson, and H.H. Kariyawasam Mepolizumab for eosinophilic severe asthma: recent studies Expert Opin. Biol. Ther. 15 2015 909 914
18. D.S. Robinson Th-2 cytokines in allergic disease Br. Med. Bull. 56 2000 956 968
19. W.W. Busse, and R.F. Lemanske Jr. Asthma. N. Engl. J. Med. 344 2001 350 362
20. G. Jia, R.W. Erickson, D.F. Choy, S. Mosesova, L.C. Wu, O.D. Solberg, and et al. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients J. Allergy Clin. Immunol. 130 2012 647.e10-654.e10
21. M.M. Fort, J. Cheung, D. Yen, J. Li, S.M. Zurawski, S. Lo, and et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo Immunity 15 2001 985 995
22. S. Lund, H.H. Walford, and T.A. Doherty Type 2 innate lymphoid cells in allergic disease Curr. Immunol. Rev. 9 2013 214 221
23. T.Y. Halim, R.H. Krauss, A.C. Sun, and F. Takei Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation Immunity 36 2012 451 463
24. P. Licona-Limon, L.K. Kim, N.W. Palm, and R.A. Flavell TH2, allergy and group 2 innate lymphoid cells Nat. Immunol. 14 2013 536 542
25. X.Y. Zhang, J.L. Simpson, H. Powell, I.A. Yang, J.W. Upham, P.N. Reynolds, and et al. Full blood count parameters for the detection of asthma inflammatory phenotypes Clin. Exp. Allergy 44 2014 1137 1145
26. A.T. Hastie, W.C. Moore, H. Li, B.M. Rector, V.E. Ortega, R.M. Pascual, and et al. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects J. Allergy Clin. Immunol. 132 2013 72 80
27. K.W. McGrath, N. Icitovic, H.A. Boushey, S.C. Lazarus, E.R. Sutherland, V.M. Chinchilli, and et al. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic Am. J. Respir. Crit. Care Med. 185 2012 612 619
28. D.C. Cowan, J.O. Cowan, R. Palmay, A. Williamson, and D.R. Taylor Effects of steroid therapy on inflammatory cell subtypes in asthma Thorax 65 2010 384 390
29. R.A. Dweik, R.L. Sorkness, S. Wenzel, J. Hammel, D. Curran-Everett, S.A. Comhair, and et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma Am. J. Respir. Crit. Care Med. 181 2010 1033 1041
30. P. Nair, M. Kjarsgaard, S. Armstrong, A. Efthimiadis, P.M. O'Byrne, and F.E. Hargreave Nitric oxide in exhaled breath is poorly correlated to sputum eosinophils in patients with prednisone-dependent asthma J. Allergy Clin. Immunol. 126 2010 404 406
31. H.G. Ortega, M.C. Liu, I.D. Pavord, G.G. Brusselle, J.M. FitzGerald, A. Chetta, and et al. Mepolizumab treatment in patients with severe eosinophilic asthma N. Engl. J. Med. 371 2014 1198 1207
32. E.H. Bel, S.E. Wenzel, P.J. Thompson, C.M. Prazma, O.N. Keene, S.W. Yancey, and et al. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma N. Engl. J. Med. 371 2014 1189 1197
33. G. Pelaia, A. Vatrella, and R. Maselli The potential of biologics for the treatment of asthma Nat. Rev. Drug Discov. 11 2012 958 972